Russell Investments Group
BIVV

Russell Investments Group’s Bioverativ Inc. Common Stock BIVV Stock Holding History

Russell Investments Group’s Portfolio BIVV Stock Details BIVV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-496,386
Closed -$26.8M – 3096
2017
Q4 		$26.8M Sell
496,386
-101,212
-17% -$5.54M 0.04% 501
2017
Q3 		$34.1M Buy
597,598
+68,581
+13% +$4.02M 0.06% 390
2017
Q2 		$31.8M Buy
529,017
+135,261
+34% +$7.7M 0.06% 413
2017
Q1 		$21.4M Buy
+393,756
New +$19.4M 0.04% 544

Other funds holding BIVV

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
ACS
Archford Capital Strategies Swansea, Illinois $987M AUM 29.31% 1-Year Est. Return

Russell Investments Group's BIVV Position: Q1 2018 in Review

Russell Investments Group sold out of Bioverativ Inc. Common Stock (BIVV) in Q1 2018, closing a stake of 496,386 shares — an estimated $26.8M sold.

Russell Investments Group first reported a position in BIVV in Q1 2017 and held it in 4 quarters. The position peaked at $34.1M in Q3 2017. 2 funds tracked by Wall St. Rank hold BIVV as of Q1 2018.

  • Russell Investments Group reported no remaining Bioverativ Inc. Common Stock position as of Q1 2018 after selling out during the quarter.
  • Russell Investments Group sold 496,386 Bioverativ Inc. Common Stock shares in Q1 2018, an estimated $26.8M.
  • Russell Investments Group first reported a position in Bioverativ Inc. Common Stock in Q1 2017 and held it in 4 quarters.
  • Russell Investments Group's Bioverativ Inc. Common Stock position peaked at $34.1M in Q3 2017.
  • 2 funds tracked by Wall St. Rank held Bioverativ Inc. Common Stock as of Q1 2018.

Based on Russell Investments Group's 13F filing for Q1 2018, filed 11 May 2018.